Novavax | NVAX - Trade Creditors


Novavax reported $22.94M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Adma Biologics USD 31.72M 11.2M Jun/2026
Agenus USD 58.98M 12.1M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Cassava Sciences USD 39.19M 2.46M Mar/2026
Geron USD 8.8M 3.92M Jun/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
MannKind USD 11.04M 5.1M Jun/2026
Merck USD 3.83B 36M Jun/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Moderna USD 167M 6M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Novavax USD 22.94M 6.84M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
TG Therapeutics USD 213.69M 64.85M Jun/2026